Literature DB >> 9316050

The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.

S W Coons1, P C Johnson, D K Pearl.   

Abstract

OBJECTIVE: The prognostic significance of quantitative measurement of tumor proliferative activity was evaluated for oligodendroglial tumors.
METHODS: Ki-67/MIB-1 immunochemistry was used to measure proliferative activity in 81 oligodendrogliomas and oligoastrocytomas. The relationship among survival, proliferation, histological features, and clinical variables were evaluated using a Cox proportional hazards analysis.
RESULTS: After stratifying by histological grade and adjusting for age at diagnosis, there was a significant association between the Ki-67/MIB-1 labeling index (LI) (percentage of positive cells) and survival (P = 0.04). This association was illustrated further by the significantly different survival of two groups based on LI ranges of less than or equal to 5 and greater than 5 (P < 0.0001).
CONCLUSION: The poor correlation between mitotic figures and survival in oligodendrogliomas that has been reported previously emphasizes the need for an accurate method to measure proliferative activity. Our study demonstrated the usefulness of the Ki-67/MIB-1 LI and demonstrated that LI ranges can be defined for clinical application.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316050     DOI: 10.1097/00006123-199710000-00021

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  26 in total

1.  The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.

Authors:  A Korshunov; A Golanov
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Diagnosis of malignant glioma: role of neuropathology.

Authors:  Daniel J Brat; Richard A Prayson; Timothy C Ryken; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

Review 3.  PCV chemotherapy for oligodendroglioma: response analyzed on T2 weighted-MRI.

Authors:  S Diabira; M C Rousselet; E Gamelin; P Soulier; E Jadaud; P Menei
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

4.  The prognostic role of vessel productive changes and vessel density in oligodendroglioma.

Authors:  D Schiffer; I Bosone; A Dutto; N Di Vito; A Chiò
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

5.  Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumors.

Authors:  Jayant Narang; Rajan Jain; Lisa Scarpace; Sona Saksena; Lonni R Schultz; Jack P Rock; Mark Rosenblum; Suresh C Patel; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2010-08-01       Impact factor: 4.130

Review 6.  Techniques to assess the proliferative potential of brain tumors.

Authors:  Alfredo Quiñones-Hinojosa; Nader Sanai; Justin S Smith; Michael W McDermott
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

Review 7.  Low-grade glioma: supratentorial astrocytoma, oligodendroglioma, and oligoastrocytoma in adults.

Authors:  Lynn S Ashby; William R Shapiro
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

8.  Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors.

Authors:  Masayuki Kanamori; Toshihiro Kumabe; Yukihiko Sonoda; Yoshikazu Nishino; Mika Watanabe; Teiji Tominaga
Journal:  J Neurooncol       Date:  2008-12-20       Impact factor: 4.130

9.  Low-grade gliomas in older patients: a retrospective analysis of prognostic factors.

Authors:  Nader Pouratian; Melike Mut; Jay Jagannathan; M Beatriz Lopes; Mark E Shaffrey; David Schiff
Journal:  J Neurooncol       Date:  2008-08-06       Impact factor: 4.130

10.  Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue.

Authors:  Wolfgang K Pfisterer; Stephen W Coons; Fahmy Aboul-Enein; William P Hendricks; Adrienne C Scheck; Mark C Preul
Journal:  J Neurooncol       Date:  2007-11-30       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.